Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of LJP 394 in Lupus Patients With History of Renal Disease (ASPEN)

This study has been terminated.
(Interim efficacy analysis indicated it would be futile to continue study.)
Sponsor:
Information provided by:
La Jolla Pharmaceutical Company
ClinicalTrials.gov Identifier:
NCT00089804
First received: August 13, 2004
Last updated: March 30, 2009
Last verified: March 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2009
  Primary Completion Date: February 2009 (Final data collection date for primary outcome measure)